United States, Institutional

Changechevron_right
menu
search
Skip to main content

Investing at the biopharma frontier

Rebecca Sykes, CFA, Global Industry Analyst
November 2023
2024-11-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1414387544

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

The innovations happening in the biopharma industry today are some of the most exciting I’ve seen in my career

Rebecca Sykes, CFA
Portfolio Manager and Global Industry Analyst
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Expert

      Related insights

      Showing 2 of 2 Insights Posts
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

      The role of public/private collaboration

      Continue reading
      event February 2025
      2 min
      Video
      2026-01-31
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

      Private biotech: Immunology and inflammation’s third wave

      Continue reading
      event December 2024
      5 min
      Article
      2025-12-01
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

      Read next